Skip to main content
CAH logo

Cardinal Health, Inc. (CAH) Stock: Price, Forecast & Analyst Target

Cardinal Health, Inc. (CAH) — MoonshotScore 88/100 (Exceptional band), calculated Nov 18, 2026. Price $272.37 (-2.14%), as of the Nov 19, 2026 trading session; market cap $63.0B. Expected results Feb 4, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$272.37 −$5.95 (-2.14%) Market Cap $63.0B

Cardinal Health, Inc. · CAH · NYSE · Healthcare · Medical - Distribution

Research dated 2026-09-12 (results through Q4 FY2026; Q1 FY2027 not covered): Cardinal Health moves pharmaceuticals and healthcare supplies through hospitals, pharmacies, clinical facilities, physician practices, and home-care channels, while also manufacturing selected medical products and operating specialized pharmaceutical services. The case depends on whether richer gross profit and dependable cash conversion can outweigh distribution-thin margins, pharmaceutical concentration, and debt that exceeds cash.

Price as of Nov 19, 2026

Key Statistics

88 of 100

MoonshotScore v2 · Cardinal Health (CAH)

Exceptional
Business Quality Average (58)
Financial Safety Fortress (86)
Valuation Cheap (85)
Growth Durability Compounding (87)
Momentum Surging (92)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

A strong balance sheet and durable growth, at a cheap price, though quality is only decent; the market is already moving on it. Business Quality: Average; Financial Safety: Fortress; Valuation: Cheap; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $67.51B (Q1 FY2027, quarter ended Sep 2026)
  • EPS beat 8 of the last 8 reports
  • expected results Feb 4, 2027

Helping: balance-sheet strength, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for CAH (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
88Exceptional
88Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$272.37
Change on the day-2.14%
52-week range$180.45–$286.29
Market capitalisation$63.0B—
Price / earnings (trailing)36.03
Shares traded on the day1.68M
Beta (volatility vs the S&P 500)0.52

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $156, high $281, latest $272. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $281 $156 high $281 Feb 5, 2026 · Earnings results · reported above the recorded estimate · close $2261Apr 30, 2026 · Earnings results · reported above the recorded estimate · close $1952Aug 11, 2026 · Earnings results · reported above the recorded estimate · close $2353Nov 5, 2026 · Earnings results · reported above the recorded estimate · close $2724 Oct 17, 2025 Nov 19, 2026 · $272 $156Oct 17, 2025$191Oct 31, 2025$205Nov 14, 2025$212Nov 28, 2025$198Dec 12, 2025$208Dec 26, 2025$201Jan 9, 2026$208Jan 23, 2026$226Feb 6, 2026$224Feb 20, 2026$218Mar 6, 2026$208Mar 20, 2026$214Apr 2, 2026$214Apr 17, 2026$195May 1, 2026$195May 15, 2026$197May 29, 2026$224Jun 12, 2026$238Jun 26, 2026$236Jul 10, 2026$228Jul 24, 2026$236Aug 7, 2026$230Aug 21, 2026$247Sep 4, 2026$225Sep 18, 2026$228Oct 2, 2026$254Oct 16, 2026$250Oct 30, 2026$281Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Cardinal Health (CAH): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Strong
Valuation Strong
Growth Durability Strong
Momentum Strong

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Moderate
Debt/Equity Strong
ROE Negative
Gross Margin Negative

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Cardinal Health (CAH), and what does it report?

Short answer · as of

Most revenue comes from distributing branded, generic, specialty, and consumer health products rather than inventing new medicines.

Cardinal Health also runs nuclear pharmacies, produces radiopharmaceuticals, repackages drugs, manages hospital pharmacies, and provides services for manufacturers, providers, and payers.

The Medical operation manufactures, sources, and distributes Cardinal Health-branded and national-brand supplies, devices, procedure kits, and laboratory products. Reported sales therefore include enormous volumes of pharmaceutical and medical product value passing through the network; the segment mix and narrow gross margin show why revenue is vast while the retained profit on each sales dollar is small.

2 · Latest results

What do the latest results show for Cardinal Health (CAH)?

Short answer · as of

The most recent reported quarter, Q1 FY2027, carried revenue of $67.51B.

The latest annual period delivered higher revenue and net income than the preceding annual period. In the latest quarter, revenue, gross profit, and operating profit advanced from the prior period, while net income edged lower; reported earnings have repeatedly exceeded estimates even though revenue has fallen short of consensus in the latest releases.

Management expects Pharmaceutical revenue to keep growing and points to expanding management-service platforms and distribution wins that began ramping recently. It is excluding a tariff-refund benefit from the comparison baseline because that benefit was nonrecurring, making underlying profit progression the more informative test.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$67.51B Nov 5, 2026
Latest report · revenue estimate
$66.67B Nov 5, 2026
Latest report · revenue vs estimate
Above estimate Nov 5, 2026
Latest report · EPS vs estimate
Above estimate Nov 5, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 5, 2026$67.51B$66.67B$3.2600$2.9400
Aug 11, 2026$63.67B$65.15B$2.9100$2.4200
Apr 30, 2026$60.94B$62.10B$3.1700$2.7900
Feb 5, 2026$65.63B$65.08B$2.6300$2.3400
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q1 FY2027$67.51B$554M$2.38 (diluted)
Q4 FY2026$63.86B$398M$1.68 (diluted)
Q3 FY2026$60.94B$399M$1.69 (diluted)
Q2 FY2026$65.44B$467M$1.97 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Cardinal Health (CAH)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Operating cash flow has recovered sharply from earlier outflows and stayed positive through the recent run, with capital spending consuming only part of that inflow. Cash and short-term investments have also risen, but debt remains materially greater than cash, while short-term liquidity ratios sit below parity.

Cardinal Health earns a very narrow gross and operating margin on a pharmaceutical-heavy revenue base. A modest deterioration in the spread between product cost and selling price could therefore have an outsized effect on operating profit, even without a major change in sales volume; the favorable distress and accounting-quality screens do not remove that operating sensitivity.

4 · What to check next?

What should you watch next at Cardinal Health (CAH)?

Short answer · as of

The next earnings report is expected on Feb 4, 2027.

At the scheduled earnings release, compare Pharmaceutical revenue direction with management's growth expectation and look for evidence that the expanding management-service platforms and recently ramped distribution wins are contributing to gross profit, not merely sales. Recent earnings beats alongside revenue misses make gross-profit and operating-profit progression more revealing than the top line alone.

Cash conversion deserves the same attention: sustained operating inflow after capital spending would reinforce the recent recovery, while renewed working-capital outflows would weaken it. Longer-range estimates assume continued expansion in revenue and earnings, so any break in that pattern would change the expectations surrounding the business.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Cardinal Health compare with its peers?

Short answer

Cardinal Health's score ranks 5th of 10 in the bounded comparison shown, against 9 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Cardinal Health is more than a pharmaceutical wholesaler. Its nuclear pharmacies, radiopharmaceutical production, specialty services, hospital pharmacy management, branded medical products, and procedure kits create service and manufacturing exposure that a pure distributor would not have.

Nor does it resemble a drug developer or a pure medical-device manufacturer: pharmaceutical distribution remains overwhelmingly dominant in the reported revenue mix, and the consolidated economics retain the high-sales, thin-margin character of distribution. The distinctive structure is a pharmaceutical logistics engine paired with smaller specialized-service and medical-product operations.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
argenx SE (ARGX) Named competitor$942.04 Nov 19, 2026$59.2B96 5-pillar Nov 18, 2026
Guardian Pharmacy Services, Inc. (GRDN) Same industry, near in market value$46.66 Nov 19, 2026$2.96B96 5-pillar Nov 18, 2026
Edwards Lifesciences Corporation (EW) Named competitor$105.23 Nov 18, 2026$60.5B93 5-pillar Nov 18, 2026
McKesson Corporation (MCK) Same industry, near in market value$1084.43 Nov 18, 2026$125B92 5-pillar Nov 18, 2026
Cardinal Health (CAH) — this page$272.37$63.0B88
Cencora, Inc. (COR) Named competitor$341.25 Nov 19, 2026$65.1B86 5-pillar Nov 18, 2026
Haleon plc (HLN) Named competitor$9.08 Nov 18, 2026$39.8B75 5-pillar Nov 18, 2026
Henry Schein, Inc. (HSIC) Same industry, near in market value$85.69 Nov 18, 2026$9.47B73 5-pillar Nov 18, 2026
Becton, Dickinson and Company (BDX) Named competitor$212.73 Nov 19, 2026$57.9B68 5-pillar Nov 18, 2026
Prestige Consumer Healthcare Inc. (PBH) Same industry, near in market value$50.62 Nov 18, 2026$2.40B63 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$265.00 – $321.00
Consensus target
$288.27
Median target
$290.00

Consensus record · Captured .

Measured against a quoted price of $272.37 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 12, 2026

Transactions
65
Identified insiders
18
Purchases
0
Sales
31
Other transactions
34

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CAH in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.12%$28.57MTrimmed −2.8% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About CAH (Healthcare)

The last 2 questions are answered from this page's own dated data, not from the research.

Why does Cardinal Health generate so much revenue with such a thin margin?

Pharmaceutical distribution dominates the revenue mix, so the value of medicines flowing through Cardinal Health is recorded as sales while the company retains only a narrow spread. That creates enormous reported revenue without manufacturer-like margins.

What do Cardinal Health nuclear pharmacies add to the Pharmaceutical business?

They extend the business beyond conventional drug delivery into nuclear-pharmacy management and radiopharmaceutical production. Those specialized capabilities sit alongside repackaging, specialty support, and pharmacy-management services.

Why is Cardinal Health removing the tariff refund from its earnings baseline?

Management described the refund benefit as nonrecurring and excludes it to make future periods comparable with the underlying business. Operational progress therefore needs to stand without that benefit.

How important are Cardinal Health medical products beside pharmaceutical distribution?

Pharmaceutical activity is far larger in the reported revenue mix, but the Medical operation adds branded manufacturing, sourcing, procedure kits, and supply-chain relationships across hospitals, surgical centers, and laboratories. It broadens what Cardinal Health supplies without changing the company's distribution-led economics.

What is the CAH stock price today?

The last price recorded for Cardinal Health, Inc. (CAH), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the CAH price target?

The analyst consensus price target for Cardinal Health, Inc. (CAH), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 42 figures on this page — 1 from SEC filings and earnings calls, 35 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Legal name; Business description; Sector / industry (provider taxonomy); Revenue by segment; Trailing twelve-month ratio set; Cash, investments and debt; Operating cash flow by quarter (USD millions)
  • 1. What is Cardinal Health (CAH), and what does it report?: Business description; Revenue by segment; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands); Trailing twelve-month ratio set
  • 2. What do the latest results show for Cardinal Health (CAH)?: Annual revenue and net result (USD millions); Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for Cardinal Health (CAH)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash against market value; Trailing twelve-month ratio set; Revenue by segment; Distress and quality screens
  • 4. What should you watch next at Cardinal Health (CAH)?: Next earnings report; Reported versus estimated, last 8 quarters; Analyst revenue and earnings estimates (average); Management outlook — dated call excerpts; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions)
  • 5. How does Cardinal Health compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Trailing twelve-month ratio set
  • FAQ: Why does Cardinal Health generate so much revenue with such a thin margin?: Business description; Revenue by segment; Annual revenue and net result (USD millions); Trailing twelve-month ratio set
  • FAQ: What do Cardinal Health nuclear pharmacies add to the Pharmaceutical business?: Business description
  • FAQ: Why is Cardinal Health removing the tariff refund from its earnings baseline?: Management outlook — dated call excerpts
  • FAQ: How important are Cardinal Health medical products beside pharmaceutical distribution?: Business description; Revenue by segment; Trailing twelve-month ratio set
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold CAH

Funds in our ETF coverage that list CAH among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
SMI 3Fourteen Full-Cycle Trend ETF (FCTE)5.30%
Liberty One Tactical Income ETF (LOTI)2.85%
JMID ETF2.59%
SPCT ETF2.56%